Large-Scale Observational Study Launches AI-Driven Tuberculosis Management System — 31,600 Patients to Validate Clinical Decision Support Tool

References

1. 1.Ahmad, N., Ahuja, S. D., Akkerman, O. W., Alffenaar, J. C., Anderson, L. F., Baghaei, P., ... & Tiberi, S. (2018). Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis. The Lancet, 392(10150), 821-834. https://doi.org/10.1016/S0140-6736(18)31644-1
2. 2.Chakaya, J., Khan, M., Ntoumi, F., Aklillu, E., Fatima, R., Mwaba, P., ... & Zumla, A. (2021). Global Tuberculosis Report 2020 - Reflections on the Global TB burden, treatment and prevention efforts. International Journal of Infectious Diseases, 113, 269-285. https://doi.org/10.1016/j.ijid.2021.02.107
3. 3.Conradie, F., Diacon, A. H., Ngubane, N., Howell, P., Everitt, D., Crook, A. M., ... & Nix-TB Trial Team. (2020). Treatment of highly drug-resistant pulmonary tuberculosis. New England Journal of Medicine, 382(10), 893-902. https://doi.org/10.1056/NEJMoa1901814
4. 4.Huashan Hospital. (2024). Artificial Intelligence-driven Tuberculosis Landscape Analysis & Stratification Research. ClinicalTrials.gov. NCT07611695. https://clinicaltrials.gov/study/NCT07611695
5. 5.Kik, S. V., Schumacher, S., Cirillo, D. M., Churchyard, G., Boehme, C., Goletti, D., ... & Denkinger, C. M. (2022). An evaluation cascade for detection of pulmonary tuberculosis in adults. International Journal of Tuberculosis and Lung Disease, 26(8), 693-699. https://doi.org/10.5588/ijtld.21.0471
6. 6.Migliori, G. B., Thong, P. M., Akkerman, O., Alffenaar, J. W., Bastian, I., Bisero, M. S., ... & Motta, I. (2021). Worldwide effects of coronavirus disease pandemic on tuberculosis services, January-April 2020. Emerging Infectious Diseases, 27(11), 2709-2712. https://doi.org/10.3201/eid2711.203163
7. 7.Nahid, P., Dorman, S. E., Alipanah, N., Barry, P. M., Brozek, J. L., Cattamanchi, A., ... & Vernon, A. (2016). Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. Clinical Infectious Diseases, 63(7), e147-e195. https://doi.org/10.1093/cid/ciw376
8. 8.Qin, Z. Z., Sander, M. S., Rai, B., Titahong, C. N., Sudrungrot, S., Laah, S. N., ... & Creswell, J. (2019). Using artificial intelligence to read chest radiographs for tuberculosis detection: A multi-site evaluation of the diagnostic accuracy of three deep learning systems. Scientific Reports, 9(1), 15000. https://doi.org/10.1038/s41598-019-51503-3
9. 9.Tiberi, S., du Plessis, N., Walzl, G., Vjecha, M. J., Rao, M., Ntoumi, F., ... & Zumla, A. (2018). Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies. The Lancet Infectious Diseases, 18(7), e183-e198. https://doi.org/10.1016/S1473-3099(18)30110-5
10. 10.World Health Organization. (2023). Global Tuberculosis Report 2023. WHO Press. WHO/UCN/TB/2023.02. https://www.who.int/publications/i/item/9789240083851